Literature DB >> 8320430

Maternal thyroid function in pregnancy.

D Glinoer1.   

Abstract

In healthy pregnant women, the regulation of thyroid function depends upon several factors. Three factors act independently to increase thyroid hormone requirements: 1) the marked increase in the binding capacity of serum due to high TBG levels; 2) the direct stimulation of the thyroid by human chorionic gonadotropin, acting as a thyrotropic hormone; and 3) the increase in placental deiodinating activity, which may contribute to modify thyroid hormone metabolism. These stimulatory events result in a physiological adaptation of the maternal thyroid gland to pregnancy, as long as the availability of iodine for the thyroidal "machinery" remains sufficient. Our studies were performed in an area where the iodine intake is precisely at the lower limit of the needs for healthy non pregnant adult subjects (less than 100 micrograms/day). In these conditions, decreased iodine availability during gestation leads to relative iodine deficiency and hence, pregnancy constitutes a "challenge" for the thyroid gland. It was shown that excessive thyroidal stimulation occurred in as much as one third of pregnancies in Brussels, accompanied by relative hypothyroxinemia, marked elevation in serum TG levels and goitrogenesis. About 10% of women had developed a goiter at parturition, which was only partially reversible during the postpartum period. A randomized prospective trial was then undertaken in euthyroid pregnant women who were below 16 weeks of gestation at initial presentation and who fulfilled biochemical criteria of excessive thyroidal stimulation (high molar T3/T4 ratio, low normal free T4 index, elevated serum TG). Thyroid function and volume were monitored sequentially during gestation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8320430     DOI: 10.1007/BF03348861

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Monitoring thyroxine treatment during pregnancy.

Authors:  P R Larsen
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

2.  Regulation of maternal thyroid during pregnancy.

Authors:  D Glinoer; P de Nayer; P Bourdoux; M Lemone; C Robyn; A van Steirteghem; J Kinthaert; B Lejeune
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

Review 3.  The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function.

Authors:  E Roti; A Gnudi; L E Braverman
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

4.  Goiter and pregnancy: a new insight into an old problem.

Authors:  D Glinoer; M Lemone
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

5.  Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions.

Authors:  D Glinoer; M F Soto; P Bourdoux; B Lejeune; F Delange; M Lemone; J Kinthaert; C Robijn; J P Grun; P de Nayer
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

6.  Partial reversibility during late postpartum of thyroid abnormalities associated with pregnancy.

Authors:  D Glinoer; M Lemone; P Bourdoux; P De Nayer; F DeLange; J Kinthaert; B LeJeune
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

7.  Maternal and neonatal thyroid function at birth in an area of marginally low iodine intake.

Authors:  D Glinoer; F Delange; I Laboureur; P de Nayer; B Lejeune; J Kinthaert; P Bourdoux
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

  7 in total
  6 in total

1.  Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency.

Authors:  O P Soldin; R E Tractenberg; J G Hollowell; J Jonklaas; N Janicic; S J Soldin
Journal:  Thyroid       Date:  2004-12       Impact factor: 6.568

2.  Therapeutic drug monitoring during pregnancy and lactation: thyroid function assessment in pregnancy-challenges and solutions.

Authors:  Offie P Soldin
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

3.  Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study.

Authors:  Offie P Soldin; Steven J Soldin; Alexander A Vinks; Islam Younis; Helain J Landy
Journal:  Ther Drug Monit       Date:  2010-12       Impact factor: 3.681

Review 4.  Thyroid hormone testing by tandem mass spectrometry.

Authors:  Offie P Soldin; Steven J Soldin
Journal:  Clin Biochem       Date:  2010-08-04       Impact factor: 3.281

Review 5.  Iodine supplementation for women during the preconception, pregnancy and postpartum period.

Authors:  Kimberly B Harding; Juan Pablo Peña-Rosas; Angela C Webster; Constance My Yap; Brian A Payne; Erika Ota; Luz Maria De-Regil
Journal:  Cochrane Database Syst Rev       Date:  2017-03-05

6.  Nutritional Iodine Status in Pregnant Women from Health Area IV in Asturias (Spain): Iodised Salt Is Enough.

Authors:  Silvia González-Martínez; María Riestra-Fernández; Eduardo Martínez-Morillo; Noelia Avello-Llano; Elías Delgado-Álvarez; Edelmiro Luis Menéndez-Torre
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.